{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:41:55Z","timestamp":1765546915043,"version":"3.41.2"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013313","name":"Overseas Expertise Introduction Project for Discipline Innovation","doi-asserted-by":"publisher","award":["Key R&amp;D projects of Science and Technique Foundation in Sichuan Province"],"award-info":[{"award-number":["Key R&amp;D projects of Science and Technique Foundation in Sichuan Province"]}],"id":[{"id":"10.13039\/501100013313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Currently, in China, several strategies exist to prevent mother-to-child transmission (MTCT) of the hepatitis B virus (HBV). These include providing Hepatitis B vaccination and hepatitis B immunoglobulin (HBIG) injection with different types of administration and dosages. The aim of this study is threefold: first, to evaluate the economic viability of current hepatitis B vaccination strategies for preventing MTCT from a public health policy perspective; second, to optimize the current immunization strategy for preventing perinatal transmission of the HBV; and third, to offer policy options to the National Health Commission in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To simulate the disease outcome for the entire life of newborns infected with HBV, a Markov model with eight possible health states was built by using TreeAge Pro 2011 software. In the present study, the model parameters were probability and cost, which were extracted from literature and calculated using Microsoft Excel 2013. The optimal immunization strategies were identified through cost-benefit analyses. A benefit-cost ratio (BCR) &amp;gt; 1 indicated that the strategy had positive benefits and <jats:italic>vice versa<\/jats:italic>. A one-way sensitivity analysis was used to investigate the stability of the results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From a public health care system perspective, we evaluated the economic viability of 11 strategies in China. For all 11 strategies, the BCR was &amp;gt; 1, which indicated that the benefits of all the strategies were greater than the costs. We recommended strategy number 9 as being optimal. In strategy number 9, babies born to hepatitis B surface antigen (HBsAg)-positive mothers were given an HBIG (200 IU) within 24 h of birth and three injections of hepatitis -B vaccine (20-\u03bcg each) at 0, 1, and 6 months, and the strategy had a BCR of 4.61. The one-way sensitivity analysis revealed that the full vaccination coverage and effective rates of protection were two factors that greatly influenced the BCR of the different prevention strategies; other factors had little effect.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The benefits of all strategies were greater than the costs. For decision-making and application, the strategy should be based on local socio-economic conditions so that an appropriate immunization strategy can be selected.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.662442","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T13:10:57Z","timestamp":1655817057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree"],"prefix":"10.3389","volume":"10","author":[{"given":"Nan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naitong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"unstructured":"Global Hepatitis Report.2017","key":"B1"},{"key":"B2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3855\/jidc.2915","article-title":"A knowledge survey of obstetrics and gynecology staff on the prevention of mother-to-child transmission of hepatitis B virus","volume":"5","author":"Hu","year":"2013","journal-title":"J Infect Dev Ctries."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.4254\/wjh.v7.i9.1233","article-title":"Chronic hepatitis B infection in pregnancy","volume":"9","author":"Lamberth","year":"2015","journal-title":"World J Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.3748\/wjg.v18.i33.4517","article-title":"Management of chronic hepatitis B in pregnancy. World J Gastroenterol","volume":"18","author":"Han","year":"2012"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S226","DOI":"10.1016\/j.ajog.2013.10.481","article-title":"Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus (HBV). Am J Obstet Gynecol","volume":"1","author":"Eke","year":"2014"},{"key":"B6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ebch.120","article-title":"Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers","volume":"1","author":"Lee","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/rmv.1801","article-title":"Mother-to-child transmission of iHBV: review of current clinical management and prevention strategies","volume":"6","author":"Ma","year":"2014","journal-title":"Rev Med Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1016\/j.ijid.2009.09.008","article-title":"Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis","volume":"7","author":"Shi ZJ Li","year":"2010","journal-title":"Int J Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S1473-3099(15)001589","article-title":"Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy","volume":"15","author":"Thio","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/MEG.0b013e32835847c6","article-title":"Cost-effectiveness analysis of preventing mother-to-child transmission of hepatitis B by injecting hepatitis B immune globulin","volume":"12","author":"Guo","year":"2012","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B11","first-page":"103","volume-title":"Essentials of Pharmacoeconomics","author":"Rascati","year":"2014"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3760\/cma.j.issn.0254-6450.2014.01.001","article-title":"The immunization of Hepatitis B vaccine and adverse event following immunization","volume":"1","author":"Cui","year":"2014","journal-title":"Chin J Epidemiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3969\/j.issn.1005-2224.2006.01.011","article-title":"A study on correlation between immune interruption of antenatal birth in pregnant women and immune effect of hepatitis B gene vaccine in neonates","volume":"1","author":"Ma","year":"2006","journal-title":"Chin J Pract Pediatr."},{"key":"B14","first-page":"474","article-title":"Study on cost-effectiveness, benefit, utility analysis in infant inoculation Hepatitis B vaccine in Shanghai","volume":"6","author":"Wu","year":"2004","journal-title":"Chin J Epidemiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3969\/j.issn.1003-515X.2003.04.018","article-title":"Clinical study on prenatal injection of hepatitis B immunoglobulin to prevent intrauterine transmission of hepatitis B virus","volume":"4","author":"Xing","year":"2003","journal-title":"J Appl Clin Pediatr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3969\/CNKI:SUN:YXLT.0.2015-34-049","article-title":"The significance of inhalation of hepatitis B immunoglobulin in preventing the spread of maternal and child hepatitis B","volume":"15","author":"Gao","year":"2016","journal-title":"Womens Health Res."},{"key":"B17","first-page":"4817","article-title":"The significance of inhalation of hepatitis B immunoglobulin in preventing the spread of maternal and child hepatitis B","volume":"34","author":"Lan","year":"2015","journal-title":"Med Forum."},{"key":"B18","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3969\/j.issn.1007-9564.2007.07.022","article-title":"Hepatitis B immunoglobulin combined with hepatitis B vaccine to block the vertical transmission of hepatitis B virus from mother to infant","volume":"7","author":"Lin","year":"2007","journal-title":"Chin J Coal Industry Medicine."},{"key":"B19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3969\/CNKI:SUN:GDYX.0.2004-02-031","article-title":"Observation on the immune effect of hepatitis B in infants with HBsAg positive mothers","volume":"2","author":"Xuan","year":"2004","journal-title":"J Guangdong Pharmaceut Univ."},{"key":"B20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3969\/CNKI:SUN:SQYX.0.2009-06-007","article-title":"Evaluation of intervention of hepatitis B vaccine combined with hepatitis b human immunoglobulin for preventing maternal and infant vertical transmission of hepatitis B","volume":"6","author":"Yin","year":"2009","journal-title":"J Commun Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3969\/j.issn.1671-8194.2013.04.196","article-title":"Clinical observation of hepatitis B vaccine combined with hepatitis B immunoglobulin for preventing the vertical transmission of hepatitis B virus from mother to infant","volume":"4","author":"Zhao","year":"2013","journal-title":"Guide Chin Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3969\/j.issn.1001-5256.2015.08.034","article-title":"Efficacy of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing HBV mother-to-fetus transmission","volume":"8","author":"Lu","year":"2015","journal-title":"J Clin Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3969\/j.issn.1001-4411.2007.22.032","article-title":"Study On the preventive effect of mother and infant vertical transmission for HBV by HBIG","volume":"9","author":"Meng","year":"2005","journal-title":"C J Birth Health Heredity."},{"key":"B24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3969\/j.issn.1006-9534.2006.04.037","article-title":"Analysis of maternal and infant vertical transmission blockade of hepatitis B virus","volume":"4","author":"Tang","year":"2006","journal-title":"Chin J Birth Health Heredity."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.3969\/CNKI:SUN:XDYF.0.2013-21-020","article-title":"The influence of serum HBeAg in pregnant women with HBV infection on the effect of blocking mother-to-infant transmission by passive-active immunoprophylaxis","volume":"21","author":"Zhu","year":"2013","journal-title":"Modern Prev Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.7620\/zgfybj.j.issn.1001-4411.2017.04.35","article-title":"Analysis on the effects of different doses of hepatitis B vaccine for preventing maternal-neonatal transmission of hepatitis B virus","volume":"4","author":"Zhang","year":"2017","journal-title":"Matern Child Health Care Chin."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.3969\/j.issn.1001-4411.2007.19.030","article-title":"Clinical study on blocking hepatitis B virus mother-to-child transmission by hepatitis B immunoglobulin","volume":"19","author":"Ni","year":"2007","journal-title":"Matern Child Health Care Chin."},{"key":"B28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3969\/j.issn.1008-2409.2013.01.031","article-title":"The effect of application of hepatitis B hyper-immune globulin on preventing the transmission of hepatitis B virus from the mother to infant in late pregnancy","volume":"1","author":"Zeng","year":"2013","journal-title":"Acta Med Sinica."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.3969\/CNKI:SUN:ZYJK.0.2013-20-034","article-title":"Analysis on first dose of hepatitis B vaccine among neonates and screening of hepatitis B virus surface antigen among delivery women in Nanchang City","volume":"20","author":"Liao","year":"2013","journal-title":"Occupation and Health."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3969\/j.issn.1006-3110.2012.11.018","article-title":"Analysis of neonatal vaccination in Futian district from 2010-2011","volume":"11","author":"Lin","year":"2012","journal-title":"Pract Prevent Med."},{"unstructured":"China's Control of Hepatitis B has Achieved Remarkable Results2013","key":"B31"},{"volume-title":"Decision Analysis Model of Prevention Maternal-Infantile Transmission of Hepatitis B Virus Infection and Revaccination of Non- and Low-Response After Standard Schedule","year":"2013","author":"Shi","key":"B32"},{"key":"B33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3969\/j.issn.1006-916X.2005.03.010","article-title":"Long-term effect of plasma-derived vaccine in the prevention of Hepatitis B (Eighteen Years' Follow-up Study)","volume":"11","author":"Wu","year":"2005","journal-title":"Chin J Vaccin Immun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3969\/j.issn.1006-916X.2005.02.011","article-title":"Studies and analysis on immunization coverage rate of Hepatitis B(HB) vaccine and the HBsAg carrier rate of children below 3 years old and incidence rate for the past ten years in Wuhan City","volume":"11","author":"Yu","year":"2005","journal-title":"Chin J Vaccin Immun."},{"volume-title":"Report of 2004 National Planned Immunization Review","year":"2005","key":"B35"},{"key":"B36","first-page":"275","article-title":"Improvement of simple catalytic model and its application to hepatitis B virus infection. Chin J Vaccin Immun","volume":"5","author":"Luo","year":"1999"},{"key":"B37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"9663","author":"Liaw","year":"2009","journal-title":"Lancet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1098\/rspb.1993.0102","article-title":"The influence of age on the development of the hepatitis B carrier state","volume":"253","author":"Edmunds","year":"1993","journal-title":"Proc Biol Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.vaccine.2013.01.020","article-title":"Economic evaluation of universal newborn hepatitis B vaccination in China","volume":"14","author":"Lu","year":"2013","journal-title":"Vaccine."},{"key":"B40","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"2","author":"Lok","year":"2007","journal-title":"Hepatology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4065\/82.8.967","article-title":"Natural history of hepatitis B virus infection: an update for clinicians","volume":"8","author":"Pungpapong","year":"2007","journal-title":"Mayo clinic proceedings."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-010-0304-7","article-title":"Natural history of hepatitis B virus infection","volume":"1","author":"Ni","year":"2011","journal-title":"Pediat Perspect J Gastroenterol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/hep.26934","article-title":"Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China","volume":"1","author":"Toy","year":"2014","journal-title":"Hepatology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/archpedi.153.2.126","article-title":"Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysis","volume":"2","author":"Fendrick","year":"1999","journal-title":"Arch Pediatr Adolesc Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1016\/j.vaccine.2009.08.082","article-title":"Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence","volume":"48","author":"Hung","year":"2009","journal-title":"Vaccine."},{"key":"B46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/07448480309596355","article-title":"The cost effectiveness of hepatitis immunization for US college students","volume":"6","author":"Jacobs","year":"2003","journal-title":"J Am Col Health."},{"key":"B47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/eurpub\/ckm123","article-title":"Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation","volume":"3","author":"Tilson","year":"2008","journal-title":"Eur J Public Health."},{"key":"B48","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1590\/S0034-8910.2013047004529","article-title":"Incorporated antivirals for chronic hepatitis B in Brazil: a cost-effectiveness analysis","volume":"4","author":"Oliveira","year":"2013","journal-title":"Revista De Sa\u00fade P\u00fablica."},{"key":"B49","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bjid.2012.12.005","article-title":"Economic evaluation of treatments for chronic hepatitis B","volume":"4","author":"Wiens","year":"2013","journal-title":"Braz J Infect Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1524-4733.2010.00733.x","article-title":"Cost-effectiveness of nucleoside analog therapy for hepatitis B in China: a Markov analysis","volume":"5","author":"Wu","year":"2010","journal-title":"Value in Health."},{"key":"B51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/hep.23310","article-title":"Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China","volume":"2","author":"Hutton","year":"2010","journal-title":"Hepatology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.4161\/hv.29944","article-title":"Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China","volume":"10","author":"Jia","year":"2014","journal-title":"Hum Vaccin Immunother."},{"key":"B53","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s12072-016-9741-6","article-title":"Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in China","volume":"1","author":"Ke","year":"2016","journal-title":"Hepatol Int."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1016\/S2214-109X(16)30101-2","article-title":"Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis","volume":"4","author":"Nayagam","year":"2016","journal-title":"Lancet Glob Health."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1136\/gutjnl-2015-309892","article-title":"Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia","volume":"12","author":"Shimakawa","year":"2015","journal-title":"Gut."},{"key":"B56","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.vaccine.2010.10.075","article-title":"Economic evaluation of infant and adolescent hepatitis B vaccination in the UK","volume":"3","author":"Siddiqui M","year":"2011","journal-title":"Vaccine."},{"key":"B57","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3949\/ccjm.75a.07019","article-title":"Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis","volume":"12","author":"Elgouhari","year":"2008","journal-title":"Cleve Clin J Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"2","author":"Fattovich","year":"2008","journal-title":"J Hepatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e0139876","DOI":"10.1371\/journal.pone.0139876","article-title":"Cost-effectiveness and cost thresholds of generic and brand drugs in a national chronic hepatitis B treatment program in China","volume":"11","author":"Toy","year":"2015","journal-title":"PLoS ONE."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/add.13385","article-title":"An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence","volume":"9","author":"Rafia","year":"2016","journal-title":"Addiction."},{"volume-title":"Study on Main Measures and Effect to Prevent HBV Transmission From Mother to Child During Pregnancy","year":"2009","author":"Guo","key":"B61"},{"key":"B62","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.cgh.2006.05.016","article-title":"A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update","volume":"8","author":"Keeffe","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3969\/j.issn.1001-0408.2006.16.010","article-title":"Economic benefit of interferon in treatment of chronic Hepatitis B virus infection","volume":"16","author":"Lao","year":"2006","journal-title":"Chin Pharm."},{"key":"B64","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3760\/cma.j.issn.0254-6450.2011.08.006","article-title":"Estimation on the intangible cost and influencing factors for patients with hepatitis B-related diseases","volume":"8","author":"Ma","year":"2011","journal-title":"Chin J Epidemiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1002\/hep.22898","article-title":"The natural history of chronic hepatitis B virus infection","volume":"5","author":"McMahon","year":"2009","journal-title":"Hepatology."},{"key":"B66","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-2893.2009.01117.x","article-title":"Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden","volume":"7","author":"Nguyen","year":"2009","journal-title":"J Viral Hepat."},{"key":"B67","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1002\/hep.20956","article-title":"Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005","volume":"2","author":"Yim","year":"2006","journal-title":"Hepatology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3969\/j.issn.1006-916X.2005.05.014","article-title":"Study on reasonable input of expanded program on immunization in some region of China","volume":"5","author":"Yu","year":"2005","journal-title":"Chin J Vaccin Immun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3969\/j.issn.1001-568X.2011.07.003","article-title":"A Study on Hepatitis B's economic burden and impact factors analysis in Guangdong province","author":"Chen","year":"2011","journal-title":"Chin Prim Health Care."},{"key":"B70","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3736\/jcim20030219","article-title":"Analysis on economic cost of chronic hepatitis B","volume":"1","author":"Chen","year":"2003","journal-title":"Chin J Hosp Admin."},{"key":"B71","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3969\/CNKI:SUN:ZGWT.0.2014-06-014","article-title":"Analysis of the cost of hepatitis B related diseases in Changzhi City and its influencing factors","volume":"31","author":"Duan","year":"2014","journal-title":"Chin J Health Statist."},{"key":"B72","doi-asserted-by":"publisher","first-page":"CD008545","DOI":"10.1002\/14651858.CD008545.pub2","article-title":"Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus","volume":"2","author":"Eke","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3969\/j.issn.1673-9701.2011.09.053","article-title":"Research on the economic burden and its influencing factors of the patients suffering from type B viral hepatitis in Shanxi Taiyuan","volume":"9","author":"Li","year":"2011","journal-title":"Chin Modern Doct."},{"key":"B74","first-page":"1871","article-title":"Analysis on economic burden and influencing factors of hepatitis B-related diseases patients","volume":"8","author":"Li","year":"2012","journal-title":"Modern Prevent Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3760\/cma.j.issn.0254-6450.2013.03.015","article-title":"Economic burden and related factors on inpatients with HBV-related diseases in Shandong province","volume":"3","author":"Lv","year":"2013","journal-title":"Chin J Epidemiol."},{"volume-title":"Study on The Economic Burden of Hepatitis B-Related Diseases in Guangzhou and The Strategies of Hepatitis B Vaccination for Population Age 1-14 in China","year":"2011","author":"Ma","key":"B76"},{"volume-title":"Analysis on the Economic Burden of Hepatitis B From Taixing, Danyang and Zhang Jiagang Cities in Jiangsu Province","year":"2014","author":"Song","key":"B77"},{"key":"B78","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3969\/j.issn.1006-0588.2013.03.005","article-title":"Investigations on the economic burden of patients with type B Viral Hepatitis in Taiyuan","volume":"3","author":"Yu","year":"2013","journal-title":"J Changzhi Med College"},{"unstructured":"Global Health Observatory (GHO) Data","key":"B79"},{"unstructured":"Chinese Statistical Year Book in 2016","key":"B80"},{"volume-title":"Health Statistics Yearbook of China in 2011","year":"2011","first-page":"345","key":"B81"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3760\/cma.j.issn.1007-3418.2017.04.004","article-title":"Management algorithm for interrupting mother-to-child transmission of hepatitis B","volume":"7","year":"2017","journal-title":"J Clin Hepatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3760\/cma.j.issn.0254-6450.2013.03.016","article-title":"Decision tree and cost-benefit analysis on strategies related to preventing maternal-infantile transmission of hepatitis B virus infection","volume":"3","author":"Shi","year":"2013","journal-title":"Chin J Epidemiol"},{"unstructured":"Guidelines for the Prevention, Care and Treatment of Persons With Chronic Hepatitis B Infection","key":"B84"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.662442\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T13:11:23Z","timestamp":1655817083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.662442\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":84,"alternative-id":["10.3389\/fpubh.2022.662442"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.662442","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"article-number":"662442"}}